Cargando…

High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes

Molecular subtypes of muscle-invasive bladder cancer (MIBC) display differential survival and drug sensitivities in clinical trials. To date, they have not been used as a paradigm for phenotypic drug discovery. This study aimed to discover novel subtype-stratified therapy approaches based on high-co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rinaldetti, Sébastien, Zhou, Qiong, Abbott, Joshua M., de Jong, Florus C., Esquer, Hector, Costello, James C., Theodorescu, Dan, LaBarbera, Daniel V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506379/ https://www.ncbi.nlm.nih.gov/pubmed/36142576 http://dx.doi.org/10.3390/ijms231810605

Ejemplares similares

AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer
por: Agarwal, Neeraj, et al.
Publicado: (2022)

Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
por: Zuiverloon, Tahlita C.M., et al.
Publicado: (2018)

Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
por: Scholtes, Mathijs P., et al.
Publicado: (2021)

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer
por: de Jong, Florus C., et al.
Publicado: (2021)

Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer
por: Esquer, Hector, et al.
Publicado: (2021)

Live Multicellular Tumor Spheroid Models For High-Content Imaging and Screening In Cancer Drug Discovery
por: Reid, Brian G., et al.
Publicado: (2014)

Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer(1)
por: Tu, Megan M., et al.
Publicado: (2019)

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2020)

Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment
por: Huang, Liangqun, et al.
Publicado: (2019)

A Gene Expression Signature Predicts Bladder Cancer Cell Line Sensitivity to EGFR Inhibition
por: Goodspeed, Andrew, et al.
Publicado: (2018)

Occipital intermittent rhythmic delta activity (OIRDA) in pediatric focal epilepsies: A case series
por: LaBarbera, Vincent, et al.
Publicado: (2021)

Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery
por: LaBarbera, Kelsie Mozzoni, et al.
Publicado: (2021)

Invasive aspergillosis in an immunocompetent patient with fever and a cardiac mass
por: LaBarbera, Matthew, et al.
Publicado: (2011)

Robot-Assisted Radical Cystectomy in the Management of Bladder Cancer
por: Keim, Jessica L., et al.
Publicado: (2006)

FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
por: Rinaldetti, Sebastien, et al.
Publicado: (2017)

Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis
por: Ehdaie, Behfar, et al.
Publicado: (2008)

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy
por: Sikic, Danijel, et al.
Publicado: (2020)

RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment
por: Said, Neveen, et al.
Publicado: (2012)

FOXM1 predicts disease progression in non-muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

The Prognostic Value of Cell Cycle Gene Expression Signatures in Muscle Invasive, High-Grade Bladder Cancer
por: Dancik, Garrett M., et al.
Publicado: (2015)

Robust Prognostic Gene Expression Signatures in Bladder Cancer and Lung Adenocarcinoma Depend on Cell Cycle Related Genes
por: Dancik, Garrett M., et al.
Publicado: (2014)

A 20 gene model for predicting nodal involvement in bladder cancer patients with muscle invasive tumors
por: Dancik, Garrett, et al.
Publicado: (2011)

Chemotherapy does not adversely impact outcome following post‐incisional hernia repair with biomaterial mesh
por: Saied, Abdul, et al.
Publicado: (2015)

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

Identifying novel biomarkers associated with bladder cancer treatment outcomes
por: Castaneda, Peris R., et al.
Publicado: (2023)

Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling
por: Xiao, Jin-Fen, et al.
Publicado: (2021)

Mechanism of Sex Differences in Bladder Cancer: Evident and Elusive Sex-biasing Factors
por: Lam, Christa M., et al.
Publicado: (2022)

Rapid Evolution of Virus Sequences in Intrinsically Disordered Protein Regions
por: Gitlin, Leonid, et al.
Publicado: (2014)

Central Disorders of Hypersomnolence, Restless Legs Syndrome, and Surgery With General Anesthesia: Patient Perceptions
por: LaBarbera, Vincent, et al.
Publicado: (2018)

Ecological and demographic impacts of a recent volcanic eruption on two endemic patagonian rodents
por: Lacey, Eileen A., et al.
Publicado: (2019)

A prediction model for Clostridium difficile recurrence
por: LaBarbera, Francis D., et al.
Publicado: (2015)

Larrea tridentata: A novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleri
por: Bashyal, Bharat, et al.
Publicado: (2017)

Context-dependent effects of relative temperature extremes on bill morphology in a songbird
por: LaBarbera, Katie, et al.
Publicado: (2020)

High content screening for drug discovery from traditional Chinese medicine
por: Wang, Jing, et al.
Publicado: (2019)

Organisation and content of supervised group exercise for people with axial spondyloarthritis in The Netherlands
por: Hilberdink, Bas, et al.
Publicado: (2020)

Inhibition of α-glucosidase, α-amylase, and aldose reductase by potato polyphenolic compounds
por: Kalita, Diganta, et al.
Publicado: (2018)

CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)
por: Oldenburg, Darby, et al.
Publicado: (2016)

Pericyte NF-κB activation enhances endothelial cell proliferation and proangiogenic cytokine secretion in vitro
por: LaBarbera, Katherine E, et al.
Publicado: (2015)

Primary Histoplasma capsulatum Enterocolitis Mimicking Peptic and Inflammatory Bowel Disease
por: Nakshabendi, Rahman, et al.
Publicado: (2016)

A gene expression ratio-based diagnostic test for bladder cancer
por: Dong, Lingsheng, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_1urjqgoo0pnel1tbho7mjobibr